ASSESSING THE INHIBITORY PROPERTY OF Ruellia tuberosa L. EXTRACT ON CALCIUM OXALATE CRYSTALLIZATION IN VITRO

Lê Trung Sơn; Nguyễn Minh Chơn

doi:10.34238/tnu-jst.9136

ASSESSING THE INHIBITORY PROPERTY OF Ruellia tuberosa L. EXTRACT ON CALCIUM OXALATE CRYSTALLIZATION IN VITRO

About this article

Received: 02/11/23 Revised: 05/03/24 Published: 11/03/24

Authors

1. Le Trung Son , Institute of Food and Biotechnology - Can Tho University
2. Nguyen Minh Chon, Institute of Food and Biotechnology - Can Tho University

Abstract

This study evaluated the inhibition and dissolution of calcium oxalate crystals that cause kidney stones using extracts from Ruellia tuberosa L. Leaf, stem and root parts were extracted by 70% ethanol maceration. The root extract gave the highest yield of 30.58% and contained flavonoid, terpenoid and tannin compounds. The ability to inhibit nucleus formation was assessed by spectrophotometric method at 620 nm to determine the absorbance of the crystal nucleus. The leaf extract showed the strongest activity with IC50 of 5.13 mg/mL. The inhibition of crystal growth was monitored by spectrophotometry at 214 nm for 10 minutes. The leaf extract also gave the best results with IC50 of 7.15 mg/mL. The inhibition of crystal aggregation was measured at 620 nm for 6 hours, the stem extract showed the highest activity with IC50 of 7.1 mg/mL. The ability to dissolve crystals was evaluated by titration method, the stem extract achieved 51.48% dissolution at 20 mg/mL. The results showed that R. tuberosa extracts can inhibit kidney stone formation, with the leaf extract effectively inhibiting the early stages and the stem extract inhibiting the later stages and dissolving crystals. This could be a natural therapy for kidney stones. Further research should isolate the bioactive compounds responsible for this activity.

Keywords

Calcium oxalate; Crystallization inhibition; Crystal dissolution; Kidney stones; Ruellia tuberosa

Full Text:

PDF

References

[1] P. Singh, P. C. Harris, D. J. Sas, and J. C. Lieske, "The genetics of kidney stone disease and nephrocalcinosis," Nature Reviews Nephrology, vol. 18, no. 4, pp. 224-240, 2022.

[2] E. G. Onal and H. Tekgul, "Assessing kidney stone composition using smartphone microscopy and deep neural networks," BJUI Compass, vol. 3, no. 4, pp. 310-315, 2022.

[3] R. Nirmaladevi, S. Kalpana, D. Kavitha, and P. R. Padma, "Evaluation of antilithiatic potential of Hibiscus rosa-sinensis Linn, in vitro," Journal of Pharmacy Research, vol. 5, no. 8, pp. 4353-4356, 2012.

[4] S. Kalpana, R. Nirmaladevi, T. S. Rai, and P. Karthika, "Inhibition of calcium oxalate crystallization in vitro by extract of banana cultivar monthan," Int J Pharm Pharmace Sci, vol. 4, pp. 649-653, 2013.

[5] M. Oner, P. G. Koutsoukos, and W. G. Robertson, "Chapter 24 - Kidney stone formation—Thermodynamic, kinetic, and clinical aspects," in Water-Formed Deposits, Z. Amjad and K. D. Demadis, Eds.: Elsevier, 2022, pp. 511-541.

[6] S. Saha and R. J. Verma, "Inhibition of calcium oxalate crystallisation in vitro by an extract of Bergenia ciliata," Arab J Urol, vol. 11, no. 2, pp. 187-92, 2013.

[7] J. A. McAteer and A. P. Evan, "The acute and long-term adverse effects of shock wave lithotripsy," Semin Nephrol, vol. 28, no. 2, pp. 200-213, 2008.

[8] P. H. Ho, "Ruellia tuberosa L.," in An Illustrated Flora of Vietnam, vol. 3: Tre Publishing House, 2003, p. 53.

[9] D. L. Chothani and S. H. Mishra, "In vitro anti-oxidant activity of Ruellia tuberosa root extracts," Free Radicals and Antioxidants, vol. 2, no. 4, pp. 38-44, 2012.

[10] M. N. Samy, S. Sugimoto, K. Matsunami, H. Otsuka, and M. S. Kamel, "Chemical Constituents and Biological Activities of Genus Ruellia," International Journal of Pharmaceutical Sciences And Research, vol. 2, no. 6, pp. 270-279, 2015.

[11] T. H. P. Nguyen, T. K. Do, T. T. N. Nguyen, T. D. Phan, and T. H. Phung, "Acute toxicity, antibacterial and antioxidant abilities of Elephantopus mollis H.B.K. and Elephantopus scaber L," CTU Journal of Innovation and Sustainable Development, vol. 12, no. 2, pp. 9-14, 2020.

[12] T. X. T. Dai, H. B. N. Lam, and T. T. A. Vo, "Studies on antibacterial and antioxidant activities of methanolic extract from Streptocaulon juventas Merr," Can Tho University Journal of Science, vol. 40, pp. 1-6, 2015.

[13] D. K. Jha, L. Panda, P. Lavanya, S. Ramaiah, and A. Anbarasu, "Detection and confirmation of alkaloids in leaves of Justicia adhatoda and bioinformatics approach to elicit its anti-tuberculosis activity," Appl Biochem Biotechnol, vol. 168, no. 5, pp. 980-90, 2012.

[14] L. Rajanna, R. Raju, and G. S. S. Sharma, "Preliminary Phytochemical Analysis and Haemolytic Activity Assay of Tuber Extract of Ruellia tuberosa L," Research & Reviews: A Journal of Life Sciences, vol. 7, no. 3, pp. 23-27, 2017.

[15] A. Aggarwal, S. Tandon, S. K. Singla, and C. Tandon, "Diminution of oxalate induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris," Int Braz J Urol, vol. 36, no. 4, pp. 480-488, 2010.

[16] R. S. Phatak and A. S. Hendre, "In-vitro antiurolithiatic activity of Kalanchoe pinnata extract," International Journal of Pharmacognosy and Phytochemical Research, vol. 7, no. 2, pp. 275-279, 2015.

[17] A. Chaudhary, S. K. Singla, and C. Tandon, "In vitro Evaluation of Terminalia arjuna on Calcium Phosphate and Calcium Oxalate Crystallization," Indian J Pharm Sci, vol. 72, no. 3, pp. 340-345, 2010.

[18] L. Saso, G. Valentini, M. G. Leone, E. Grippa, and B. Silvestrini, "Development of an in vitro assay for the screening of substances capable of dissolving calcium oxalate crystals," Urol Int, vol. 61, no. 4, pp. 210-214, 1998.

[19] U. Atodariya, R. Barad, S. Upadhyay, and U. Upadhyay, "Anti-urolithiatic activity of Dolichos biflorus seeds," Journal of Pharmacognosy and Phytochemistry, vol. 2, no. 2, pp. 37-52, 2013.

[20] M. Zarrow, Experimental Endocrinology: A Sourcebook of Basic Techniques. Elsevier, 2012, pp. 387-389.

[21] H. Bandar, A. Hijazi, H. Rammal, A. Hachem, Z. Saad, and B. Badran, "Techniques for the extraction of bioactive compounds from Lebanese Urtica Dioica," American Journal of Phytomedicine and Clinical Therapeutics, vol. 1, no. 6, pp. 507-513, 2013.

[22] A. Safitri, A. Roosdiana, I. Rosyada, C. A. Evindasari, Z. Muzayyana, and R. Rachmawanti, "Phytochemicals screening and anti-oxidant activity of hydroethanolic extracts of Ruellia tuberosa L.," IOP Conference Series: Materials Science and Engineering, vol. 509, no. 1, 2019, Art. no. 012017.

[23] R. R. Gupta et al., "Prevalence and risk factors for kidney stones in fibrodysplasia ossificans progressiva," Bone, vol. 109, pp. 120-123, 2018.

[24] M. Gupta, S. Bhayana, and S. K. Sikka, "Role of urinary inhibitors and promoters in calcium oxalate crystallisation," Int J Research in Pharmacy and Chemistry, vol. 1, pp. 793-798, 2011.

[25] M. R. de Cogain et al., "Aqueous extract of Costus arabicus inhibits calcium oxalate crystal growth and adhesion to renal epithelial cells," Urolithiasis, vol. 43, no. 2, pp. 119-24, 2015.

[26] N. Cheraft-Bahloul et al., "Protective Effects of Pistacia lentiscus L. fruit extract against calcium oxalate monohydrate induced proximal tubular injury," J Ethnopharmacol, vol. 209, pp. 248-254, 2017.

[27] F. Atmani and S. R. Khan, "Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro," BJU Int, vol. 85, no. 6, pp. 621-625, 2000.

[28] M. M. Malini, M. Lenin, and P. Varalakshmi, "Protective effect of triterpenes on calcium oxalate crystal-induced peroxidative changes in experimental urolithiasis," Pharmacol Res, vol. 41, no. 4, pp. 413-418, 2000.

"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:

minor-latin;mso-bidi-theme-font:minor-bidi;mso-ansi-language:PT-BR;mso-fareast-language:

EN-US;mso-bidi-language:AR-SA'>

DOI: https://doi.org/10.34238/tnu-jst.9136

Refbacks

There are currently no refbacks.



Remember me